is retatrutide approved in other countries Retatrutide, an experimental weight-loss drug, has not been by the FDA. But, doctors and nurse practitioners clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide, an experimental weight-loss drug,

People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open

If the late data keeps tracking Phase 2, Health Canada and FDA approval looks plausible around 2027 or 2028

However, more receptors also means more pharmacological complexity

For current program pricing and a personalized assessment of candidacy, schedule a private consultation with our clinical team

This episode is brought to you by Sunlighten Saunas Want a gentle, science-forward way to sweat, recover, and unwind